Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally. The company offers...
26 insider purchases on record · latest filing 2025-06-06.
Insiders have also filed 1 sale transaction at IOVA.